Trading Members of the Exchange are hereby informed that effective from Thursday, February 8, 2018 the Equity Shares of Medico Remedies Limited shall be listed and admitted to dealings on the SME Platform of Exchange in the list of ‘M’ Group of Securities.
Name of the company
|
Securities
|
Market Lot
|
Scrip Code
|
Medico Remedies Limited
|
41,49,200 equity shares of Rs. 10/- each fully paid up
Distinctive Nos.
1 to 4149200
|
1,200 Shares
|
540937
|
50, Juhu Supreme Shopping Center, Gulmahor Cross Road No. 9,
Juhu, Mumbai-400049
Tel: +91 22 2670 1055/66
Fax No.: +91 22 2628 1059
E-mail: info@medicoremedies.com
Website: www.medicoremedies.com
|
Abbreviated name on bolt system
MEDICO
|
Scrip ID on BOLT System
MEDICO
|
ISIN No.
INE630Y01016
|
Issue Price:
Rs.100/- per share
|
Date of Allotment in the public issue:
February 6, 2018
|
1. Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e. 1200 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.
2. Trading Members are requested to note that the above security will be available for trading in continuous trading session.
3. Trading Members may note that the shares bearing the distinctive numbers, the details of which are attached as Annexure I, are not transferable till the date(s) mentioned against them and would not be a good delivery in the market till then. The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.
4. A copy of shareholding pattern submitted by the company is enclosed as Annexure II.
5. The company’s financial year ending is March 31.
6. All shares are ranking pari-passu including dividend entitlement
7. The Market Maker to the issue as mentioned in the prospectus is given below:
ARYAMAN CAPITAL MARKETS LIMITED
60, Khatau Building, Ground Floor,
Alkesh Dinesh Modi Marg
Opp. P. J. Tower (BSE Building),
Fort, Mumbai - 400001
Tel: +91 22 6216 6999
Fax No.: +91 22 2263 0434
Email: aryacapm@gmail.com
Contact Person: Mr. Harshad Dhanawade
SEBI Registration No.: INB011465938
Market Maker Reg. No.: SMEMM0651421122012
8. The Registrar to the issue as mentioned in the prospectus is given below:
CAMEO CORPORATE SERVICES LIMITED
Subramanian Building No. 1,
Club House Road
Chennai – 600 002
Tel No.: +91 44 2846 0390/ 1989
Fax No.: +91 44 2846 0129
Email: cameo@cameoindia.com
Website: www.cameoindia.com
Contact Person: Mr. R. D. Ramasamy
SEBI Registration No.: INR 000003753
In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
a) At the company:
Mr. Vipul Dubey,
Company Secretary & Compliance Officer
|
Registered Office:
50, Juhu Supreme Shopping Center, Gulmahor Cross Road No. 9,
Juhu, Mumbai-400049
Tel: +91 22 2670 1055/66
Fax No.: +91 22 2628 1059
E-mail: info@medicoremedies.com
Website: www.medicoremedies.com
|
b) At the Exchange:
Rupal Khandelwal
Manager
|
Tel.: (91) 022 22728262
|
Rupal Khandelwal
Manager
Wednesday, February 7, 2018 |